PRESS STATEMENT: 31 March 2023 FOR IMMEDIATE RELEASE
Ketamine Infusions Offer New Hope for Mental Health Treatment: Prof Shabir Moosa Shares Insights in Clinix Group Webinar
JOHANNESBURG, South Africa – March 31, 2023 – Prof Shabir Moosa, medical director of AYZA Health, presented an enlightening and engaging online continuing professional development (CPD) webinar on "Mental Health and the potential for Ketamine" to over 150 health professionals, in partnership with the Clinix Group in South Africa.
The well-received presentation discussed the growing interest in the use of ketamine infusions as a promising treatment for various mental health conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). Prof Moosa shared compelling research findings, clinical observations, and patient experiences that demonstrated the effectiveness of ketamine as a novel and rapid-acting therapy for those struggling with mental health challenges.
As an experienced practitioner and advocate for innovative mental health care solutions, Prof Moosa highlighted the unique mechanisms of ketamine's action on the brain, which sets it apart from conventional antidepressants. He emphasized the importance of understanding the potential benefits and risks associated with ketamine treatment and called for further research and collaboration among mental health professionals, researchers, and policymakers to optimize its therapeutic potential.
During the webinar, Prof Moosa addressed critical questions from the participants, including the safety profile of ketamine, the ideal patient population for this treatment, and the practicalities of administering ketamine infusions in a clinical setting. Attendees praised the presentation for its comprehensive and balanced approach to the subject matter, noting that it effectively conveyed the current state of knowledge and the exciting possibilities that ketamine infusions may offer in the future.
AYZA Health (www.ayzahealth.co.za), under the leadership of Prof Shabir Moosa (profmoosa@ayzahealth.co.za), is committed to providing evidence-based, cutting-edge mental health solutions that empower healthcare professionals and patients alike. By participating in events like the Clinix Group's online CPD webinar series, AYZA Health is contributing to the global conversation on mental health and raising awareness about emerging treatments such as ketamine infusions.
For more information about AYZA Health or to learn more about ketamine infusions for mental health treatment, please visit www.ayzahealth.co.za or contact Prof Shabir Moosa at profmoosa@ayzahealth.co.za. recording of Prof Moosa's CPD presentation on the potential for Ketamine in mental health treatment is also available at https://www.ayzahealth.co.za/ketamine-news.
Comentarios